Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 2/20 | 0.55 |
| ▸ | NPC1 | O15118 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | IDO1 | P14902 | 2/20 | 0.50 |
| ▸ | PAM | P19021 | 1/20 | 0.50 |
| ▸ | MAOB | P27338 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL387862 | 1.00 | RAB9A (0.55) | RAB9ANPC1TDP1L3MBTL1IDO1 | |
| SCHEMBL4265198 | 0.91 | RAB9A (0.52) | RAB9ANPC1TDP1L3MBTL1IDO1 | |
| SCHEMBL3479361 | 0.89 | RAB9A (0.47) | RAB9ANPC1TDP1L3MBTL1IDO1 | |
| SCHEMBL3479354 | 0.89 | RAB9A (0.47) | RAB9ANPC1TDP1L3MBTL1IDO1 | |
| SCHEMBL7161394 | 0.87 | RAB9A (0.49) | RAB9ANPC1TDP1L3MBTL1IDO1 | |
| SCHEMBL13138358 | 0.85 | RAB9A (0.47) | RAB9ANPC1TDP1L3MBTL1IDO1 | |
| SCHEMBL11739225 | 0.81 | RAB9A (0.52) | RAB9ANPC1TDP1L3MBTL1IDO1 | |
| SCHEMBL9786198 | 0.81 | RAB9A (0.52) | RAB9ANPC1TDP1L3MBTL1IDO1 | |
| SCHEMBL6916286 | 0.79 | RAB9A (0.59) | RAB9ANPC1TDP1L3MBTL1IDO1 | |
| SCHEMBL6916282 | 0.79 | RAB9A (0.59) | RAB9ANPC1TDP1L3MBTL1IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2086929-B1 | ALLYLIC POLYSULFANES | ECOSPRAY LTD (GB) | 2016-03-30 | — | — | EP | disclosed |
| US-8101802-B2 | Allylic polysulfanes | ECOSPRAY LIMITED (GB) | 2012-01-24 | — | — | US | disclosed |
| US-20100274037-A1 | ALLYLIC POLYSULFANES | ECOSPRAY LIMITED (GB) | 2010-10-28 | — | — | US | disclosed |
| EP-2086929-A1 | ALLYLIC POLYSULFANES | Ecospray Limited (GB) | 2009-08-12 | — | — | EP | disclosed |
| WO-2008059217-A1 | ALLYLIC POLYSULFANES | ECOSPRAY LIMITED (GB) | 2008-05-22 | — | — | WO | disclosed |
| WO-2004039771-A1 | DIALLYLDISULPHIDE COMPOUNDS HAVING ANTILIPIDEMIC AND ANTIOXIDANT ACTIVITY | DEPARTMENT OF SCIENCE AND TECHNOLOGY (IN) | 2004-05-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100274037-A1 | ALLYLIC POLYSULFANES | MPST, TST, CBS | RAB9A 4765/4885NPC1 3758/4885TDP1 4500/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.